1. Agah R, Malloy B, Sherrod A, Mazumder A. Successfultherapy of natural killer-resistant pulmonary metastases by the synergism of7-interferon with tumour necrosis factor and interleukin-2 in mice. Cancer Res 1988; 48: 2245–8.
2. Aguet M, Mogensen KE. Interferon receptors. In: Gresser I, (editor).Interferon 3. New York: AcademicPress, 1983: 1–22.
3. Aprile JA, RussoM, Pepe MS, Loughran TP. Activation signals leading to proliferation of normaland leukemic CD3+ large granular lymphocytes. Blood 1991; 78: 1282–5.
4. AtzpodienJ, Shimazaki C, Wisniewski D, et al. Interleukin-2 und Interferon- in deradoptiven Immuntherapie des Plasmozytoms: Ein experimentelles Modell. In: LutzD, Heinz R, Nowotny H, Stacher A, et al. (editors). Leukämien und Lymphome.München, Wien, Baltimore: Urban & Schwarzenberg 1988: 211–2.
5. Atzpodien J,Kirchner H. Cancer, cytokines, and cytotoxic cells: Interleukin-2 in theimmunotherapy of human neoplasms. Klin Wochenschr 1990; 68: 1–11.